CVLB - Conversion Labs, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1560
+0.0060 (+4.00%)
At close: 3:56PM EST
Stock chart is not supported by your current browser
Previous Close0.1500
Open0.1550
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1550 - 0.1565
52 Week Range0.0800 - 0.2000
Volume92,408
Avg. Volume64,157
Market Cap8.331M
Beta (3Y Monthly)2.37
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • GlobeNewswire

    Conversion Labs Announces Official Launch of Men’s Telehealth Brand Rex MD

    Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on creating and scaling proprietary health and wellness brands, today announced its official launch of Rex MD, a male-oriented telemedicine brand. Customers can now visit www.rexmd.com where they can be diagnosed and prescribed prescription medications that are discretely delivered to their home. Rex MD is initially focused on the treatment of erectile dysfunction and will offer additional prescription medications for men in the coming months.

  • GlobeNewswire

    Conversion Labs Announces FDA 510(k) Submission for its Laser Therapy Hair Regrowth System

    Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on creating and scaling proprietary health and wellness brands, today announced it has filed a 510(k) submission with the U.S. Food and Drug Administration (FDA) for approval of its Low-Level Laser Therapy (“LLLT”) Shapiro MD Laser Cap System. The Shapiro MD Laser Cap System is a portable device intended for hair regrowth utilizing low-level laser therapy technology. “Our submission of the 510(k) application to the FDA represents our ongoing commitment to building the Shapiro MD product line into the most robust portfolio of clinically proven/studied hair loss products in the United States,” said Stefan Galluppi, CTO and COO of Conversion Labs.

  • GlobeNewswire

    Conversion Labs Ranked Number 189 Fastest Growing Company in North America on Deloitte’s 2019 Technology Fast 500™

    Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on creating and scaling proprietary health and wellness brands, today announced it ranked #189 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in North America now in its 25th year. Overall, 2019 Technology Fast 500™ companies achieved revenue growth ranging from 166 percent to 37,458 percent from 2015 to 2018, with median growth of 439 percent.

  • GlobeNewswire

    Conversion Labs Reports LegitScript Certifications and Launch of Telemedicine Business

    NEW YORK, Oct. 18, 2019 -- Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on creating and scaling proprietary.

  • GlobeNewswire

    Conversion Labs Reports Record Third Quarter 2019 Revenue

    Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on creating and scaling proprietary health and wellness brands, today announced its unaudited financial results for the third fiscal quarter of 2019. Conversion Labs and its majority owned SaaS subsidiary, LegalSimpli Software LLC (“LegalSimpli”), collectively achieved record gross revenues of $3.55 Million in the third quarter, representing growth of 42.2%, compared to the same period one year ago. The Company anticipates continued revenue growth from all business units and from the launch of its telemedicine brands this quarter.

  • GlobeNewswire

    Conversion Labs CEO Justin Schreiber Interviewed on NewsMax TV

    Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on building and scaling proprietary health and wellness brands, today announced that the Company’s Chairman and CEO, Justin Schreiber, was interviewed on NewsMax TV's show, Liquid Lunch with John Tobacco, on Monday September 30, 2019. Mr. Schreiber discussed the industry and consumer trends driving the growth of the telemedicine sector and Conversion Labs' upcoming launch of its first two generic prescription drug brands later this quarter.

  • GlobeNewswire

    Conversion Labs Announces PDF Simpli Milestone of Over 2 Million Registered Users

    Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on building and scaling proprietary health and wellness brands, today announced that PDF Simpli achieved a milestone of over 2 million registered users of its PDF Simpli software product. PDF Simpli is owned by Legal Simpli Software LLC, a majority owned subsidiary of Conversion Labs.

  • GlobeNewswire

    Conversion Labs to Present at the Fall Investor Summit on September 16th-17th in New York City

    Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on building and scaling proprietary online health and wellness brands, today announced that Justin Schreiber, Chairman and Chief Executive Officer of Conversion Labs, will present a company overview at the Fall Investor Summit on Tuesday, September 17, 2019, at 2:30 p.m. Eastern Time at the JW Marriott Essex House in New York, NY. A live audio webcast of the presentation will be available on the Investors section of Conversion Labs’ website at https://ir.conversionlabs.com/ir-calendar where it will be archived for approximately 30 days. Conversion Labs, Inc. (the "Company") is an e-commerce and telemedicine company with a portfolio of proprietary online brands.

  • GlobeNewswire

    Conversion Labs Reports to Present at Upcoming Investor Conferences in September

    Conversion Labs, Inc. (the "Company") is an e-commerce and telemedicine company with a portfolio of proprietary online brands. The Company’s portfolio consists of commercial stage, over-the-counter health and wellness products in the hair loss, immune support, scarring and bruising verticals.

  • GlobeNewswire

    Conversion Labs Reports 32% Year-Over-Year Sales Growth; Announces Completion of Bridge Financing for $1.29 Million

    Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on building and scaling proprietary online brands, today reported financial results for the Second Quarter of 2019 and the six months ended June 30, 2019, and announced the completion of a bridge financing (the “Bridge Financing”). Gross profits rose 47.5% to $5.397 Million, as a result of higher revenues.  The Company had a net operating loss for the quarter of $833,165. The Company entered into securities purchase agreements (the “Purchase Agreements”) with three accredited investors, where pursuant to the terms of the Purchase Agreements, the Company issued and sold to the investors promissory notes for the aggregate principal amount of $1,291,500 convertible into shares of the Company’s common stock at $0.23 per share and warrants to purchase up to 4,679,348 shares of the Company’s common stock at an exercise price of $0.28 per share.

  • GlobeNewswire

    Conversion Labs Strengthens Board of Directors with Appointment of Two New Directors

    Conversion Labs, Inc. (CVLB) (the “Company” or “Conversion Labs”), an e-commerce company that builds proprietary consumer products and software brands, today announced that it has appointed Happy Walters and Bertrand Velge to its Board of Directors (the “Board”) effective June 11, 2019. In addition, the Company’s President, CEO and largest shareholder, Justin Schreiber will assume the role of Chairman of the Board.

  • GlobeNewswire

    Conversion Labs Announces Telemedicine Joint Venture and Strategic Partnership with GoGoMeds

    Conversion Labs, Inc. (CVLB) (the “Company” or “Conversion Labs”), an e-commerce company focused on creating, acquiring and scaling proprietary consumer products and software, today announced that it has entered into a telemedicine joint venture and strategic partnership agreement with GoGoMeds.com. GoGoMeds is one of the largest and fastest growing online pharmacies in the United States, licensed to dispense and ship prescription drugs to patients in all 50 states and the District of Columbia. In 2016, the top 20 leading drug store chains in the US captured $225.30 billion in prescription drug sales.

  • GlobeNewswire

    Conversion Labs Announces PDF Simpli Achieves Milestone of Over 1 Million Registered Users

    Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products, today announced that the Company’s majority owned subsidiary, LegalSimpli Software LLC, achieved a milestone of over 1 million registered users of its PDF Simpli software product.

  • GlobeNewswire

    Conversion Labs to Host Conference Call This Afternoon to Discuss FY 2018 and 2019 Expectations

    Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products, will be hosting a conference call today to discuss the results of Fiscal Year 2018, preliminary figures for First Quarter 2019, and plans for the remainder of Fiscal Year 2019. Conversion Labs reported record yearly revenues of $8.324M for the 2018 Fiscal Year, where the company divested its legacy manufacturing business and expanded its e-commerce portfolio. In preliminary results for 2019, the Company estimates record gross revenue of approximately $3.03 million for Q1 2019, in which March is estimated to have generated $1.32 million.

  • GlobeNewswire

    Conversion Labs Announces Record Monthly and Quarterly Sales; Results To Be Discussed In Upcoming Conference Call

    The Company will be hosting a conference call this week to discuss these results and provide additional detail on the Company’s plan for growth in 2019. Conversion Labs’ portfolio of brands experienced strong sales growth in the first quarter of fiscal year 2019. Driven primarily by sales of Shapiro MD, the Company estimates record gross revenue of approximately $3.03 million for Q1 2019.  March 2019 was the strongest month in the history of the Company with combined gross revenues of LegalSimpli Software and Conversion Labs PR totaling approximately $1.32 million.

  • GlobeNewswire

    Conversion Labs to Host Conference Call on April 10 2019 to Discuss Fiscal Year 2018 Results

    Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products, will be hosting a conference call to discuss its corporate and financial results for the Fiscal Year ended 2018 and plans for upcoming fiscal year 2019. "2018 was a year in which we diversified operations and made big investments in infrastructure and human capital that we believe will provide a foundation for strong future growth,” stated Justin Schreiber, President and CEO of Conversion Labs.

  • GlobeNewswire

    Conversion Labs Announces Robust Sales Traction To Start 2019

    Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products and software, today announced promising sales data to start 2019, driven by sales of the Company’s two main products Shapiro MD and iNR Wellness MD as well as recently launched Scarology. Conversion Labs’ portfolio of products experienced strong demand to start fiscal year 2019.